Early diabetes study tests natural hormone to boost insulin
NCT ID NCT02724566
Summary
This small, early-stage study tested whether a hormone called apelin can improve how the body uses insulin in people with type 2 diabetes. Nine volunteers with well-controlled diabetes received a continuous infusion of apelin or a placebo. The main goal was to see if apelin made the body more sensitive to insulin, which could inform the development of new future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospitals of Toulouse (Rangueil)
Toulouse, Midi-Pyrénées, 31059, France
Conditions
Explore the condition pages connected to this study.